Aethlon Medical
AEMD
14 hedge funds and large institutions have $4.18M invested in Aethlon Medical in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
17% more funds holding
Funds holding: 12 → 14 (+2)
3% more call options, than puts
Call options by funds: $401K | Put options by funds: $388K
2% more capital invested
Capital invested by funds: $4.08M → $4.18M (+$94K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$437K |
| 2 |
BlackRock
New York
|
+$269K |
| 3 |
Renaissance Technologies
New York
|
+$218K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$134K |
| 5 |
Bank of New York Mellon
New York
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$161K |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$98K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$67.2K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$16.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.8K |
AEMD Hedge Fund Activity: Q3 2021 in Review
14 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2021, worth a combined $4.18M — up 2.3% from $4.08M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AEMD positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $437K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $161K sold.
- 14 institutional investors held Aethlon Medical (AEMD) as of Q3 2021, up from 12 in Q2 2021.
- Funds reported $4.18M of Aethlon Medical stock for Q3 2021, up 2.3% quarter-over-quarter.
- 5 funds opened new Aethlon Medical positions in Q3 2021 and 3 closed out, a net change of +2 holders.
- The largest Aethlon Medical buyer in Q3 2021 was Dimensional Fund Advisors, an estimated $437K added.
- The largest Aethlon Medical seller in Q3 2021 was Two Sigma Investments, an estimated $161K sold.
Based on aggregated 13F filings for Q3 2021.